LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. The company has market cap of $202.57 million. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs. It has a 35.28 P/E ratio. The firm also provides skin care products, including ultra gentle facial cleanser, perfecting lotion, eye corrector serum, anti-aging cream, hand cream, and micro-lift serum under the TrueScience brand name.
More notable recent LifeVantage Corporation (NASDAQ:LFVN) news were published by: Nasdaq.com which released: “Market Trends Toward New Normal in Neuralstem, Industrial Services of America, Gulf Resources, Natural Alternatives International, Lifevantage, and Lonestar Resources US â€” Emerging Consolidated Expectations, Analyst Ratings – Nasdaq” on November 19, 2018, also Benzinga.com with their article: “48 Biggest Movers From Yesterday – Benzinga” published on November 30, 2018, Seekingalpha.com published: “LifeVantage Corporation (LFVN) CEO Darren Jensen on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” on August 15, 2018. More interesting news about LifeVantage Corporation (NASDAQ:LFVN) were released by: Nasdaq.com and their article: “After-Hours Earnings Report for August 15, 2018 : CSCO, NTAP, CACI, SPTN, BGG, LFVN – Nasdaq” published on August 15, 2018 as well as Globenewswire.com‘s news article titled: “LifeVantage Expands in Europe, Launches in Austria Nasdaq:LFVN – GlobeNewswire” with publication date: September 05, 2018.